1. Home
  2. CMPS vs ACCD Comparison

CMPS vs ACCD Comparison

Compare CMPS & ACCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • ACCD
  • Stock Information
  • Founded
  • CMPS 2020
  • ACCD 2007
  • Country
  • CMPS United Kingdom
  • ACCD United States
  • Employees
  • CMPS N/A
  • ACCD N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • ACCD Business Services
  • Sector
  • CMPS Health Care
  • ACCD Consumer Discretionary
  • Exchange
  • CMPS Nasdaq
  • ACCD Nasdaq
  • Market Cap
  • CMPS 280.2M
  • ACCD 281.1M
  • IPO Year
  • CMPS 2020
  • ACCD 2020
  • Fundamental
  • Price
  • CMPS $4.09
  • ACCD $3.53
  • Analyst Decision
  • CMPS Strong Buy
  • ACCD Buy
  • Analyst Count
  • CMPS 6
  • ACCD 12
  • Target Price
  • CMPS $33.60
  • ACCD $8.96
  • AVG Volume (30 Days)
  • CMPS 666.3K
  • ACCD 1.0M
  • Earning Date
  • CMPS 10-31-2024
  • ACCD 01-09-2025
  • Dividend Yield
  • CMPS N/A
  • ACCD N/A
  • EPS Growth
  • CMPS N/A
  • ACCD N/A
  • EPS
  • CMPS N/A
  • ACCD N/A
  • Revenue
  • CMPS N/A
  • ACCD $441,028,000.00
  • Revenue This Year
  • CMPS N/A
  • ACCD $14.58
  • Revenue Next Year
  • CMPS N/A
  • ACCD $12.65
  • P/E Ratio
  • CMPS N/A
  • ACCD N/A
  • Revenue Growth
  • CMPS N/A
  • ACCD 16.04
  • 52 Week Low
  • CMPS $3.86
  • ACCD $3.08
  • 52 Week High
  • CMPS $12.75
  • ACCD $15.36
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 35.91
  • ACCD 43.33
  • Support Level
  • CMPS $3.86
  • ACCD $3.41
  • Resistance Level
  • CMPS $4.20
  • ACCD $3.61
  • Average True Range (ATR)
  • CMPS 0.28
  • ACCD 0.16
  • MACD
  • CMPS 0.00
  • ACCD -0.02
  • Stochastic Oscillator
  • CMPS 8.06
  • ACCD 35.10

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About ACCD Accolade Inc.

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Share on Social Networks: